Glenn E Green1, Farhan S Huq, Sarah B Emery, Suresh K Mukherji, Donna M Martin. 1. *University of Michigan Department of Otolaryngology-Head and Neck Surgery, Division of Pediatric Otolaryngology, †University of Michigan Medical School, ‡University of Michigan Department of Human Genetics, §University of Michigan Department of Radiology, and ∥University of Michigan Departments of Pediatrics and Human Genetics, University of Michigan Health System, Ann Arbor, Michigan, U.S.A.
Abstract
OBJECTIVE: To determine whether patients with semicircular canal dysplasia have mutations in CHD7. BACKGROUND: CHARGE syndrome is a nonrandom clustering of congenital anomalies, including ocular coloboma, heart defects, choanal atresia or stenosis, retarded growth and development, genital hypoplasia, and inner and outer ear anomalies including deafness. Semicircular canal dysplasia has been included as a major diagnostic criterion for CHARGE syndrome. Mutations in the gene CHD7 on chromosome 8q12.1 are a major cause of CHARGE syndrome, but the extent to which patients with semicircular canal dysplasia have CHD7 mutations is not fully understood. STUDY DESIGN: Cross-sectional analysis of CHD7 in 12 patients with semicircular canal dysplasia and variable clinical features of CHARGE syndrome. RESULTS: We identified 6 CHD7 mutations, 5 of which occurred in patients who fulfilled Verloes' diagnostic criteria for typical CHARGE syndrome, and three of which were previously unreported. Of the 3 remaining CHD7 mutation-positive patients, one had atypical CHARGE by diagnostic criteria. Four MRI records were available, which revealed 2 patients with cochlear nerve aplasia and 1 patient with Chiari 1 malformation. CONCLUSION: These data provide additional evidence that CHD7 mutations are a significant cause of semicircular canal atresia in children with full or partial CHARGE syndrome.
OBJECTIVE: To determine whether patients with semicircular canal dysplasia have mutations in CHD7. BACKGROUND:CHARGE syndrome is a nonrandom clustering of congenital anomalies, including ocular coloboma, heart defects, choanal atresia or stenosis, retarded growth and development, genital hypoplasia, and inner and outer ear anomalies including deafness. Semicircular canal dysplasia has been included as a major diagnostic criterion for CHARGE syndrome. Mutations in the gene CHD7 on chromosome 8q12.1 are a major cause of CHARGE syndrome, but the extent to which patients with semicircular canal dysplasia have CHD7 mutations is not fully understood. STUDY DESIGN: Cross-sectional analysis of CHD7 in 12 patients with semicircular canal dysplasia and variable clinical features of CHARGE syndrome. RESULTS: We identified 6 CHD7 mutations, 5 of which occurred in patients who fulfilled Verloes' diagnostic criteria for typical CHARGE syndrome, and three of which were previously unreported. Of the 3 remaining CHD7 mutation-positive patients, one had atypical CHARGE by diagnostic criteria. Four MRI records were available, which revealed 2 patients with cochlear nerve aplasia and 1 patient with Chiari 1 malformation. CONCLUSION: These data provide additional evidence that CHD7 mutations are a significant cause of semicircular canal atresia in children with full or partial CHARGE syndrome.
Authors: M C J Jongmans; R J Admiraal; K P van der Donk; L E L M Vissers; A F Baas; L Kapusta; J M van Hagen; D Donnai; T J de Ravel; J A Veltman; A Geurts van Kessel; B B A De Vries; H G Brunner; L H Hoefsloot; C M A van Ravenswaaij Journal: J Med Genet Date: 2005-09-09 Impact factor: 6.318
Authors: A K Morimoto; R H Wiggins; P A Hudgins; G L Hedlund; B Hamilton; S K Mukherji; S A Telian; H R Harnsberger Journal: AJNR Am J Neuroradiol Date: 2006-09 Impact factor: 3.825
Authors: Erika A Bosman; Andrew C Penn; John C Ambrose; Ross Kettleborough; Derek L Stemple; Karen P Steel Journal: Hum Mol Genet Date: 2005-10-05 Impact factor: 6.150
Authors: Têmis M Félix; Benjamin C Hanshaw; Robert Mueller; Pierre Bitoun; Jeffrey C Murray Journal: Am J Med Genet A Date: 2006-10-01 Impact factor: 2.802
Authors: D Sanlaville; H C Etchevers; M Gonzales; J Martinovic; M Clément-Ziza; A-L Delezoide; M-C Aubry; A Pelet; S Chemouny; C Cruaud; S Audollent; C Esculpavit; G Goudefroye; C Ozilou; C Fredouille; N Joye; N Morichon-Delvallez; Y Dumez; J Weissenbach; A Munnich; J Amiel; F Encha-Razavi; S Lyonnet; M Vekemans; T Attié-Bitach Journal: J Med Genet Date: 2005-09-16 Impact factor: 6.318
Authors: Elizabeth A Hurd; Patrice L Capers; Marsha N Blauwkamp; Meredith E Adams; Yehoash Raphael; Heather K Poucher; Donna M Martin Journal: Mamm Genome Date: 2007-02-28 Impact factor: 2.957
Authors: O Giray Bozkaya; E Ataman; C Randa; D Onur Cura; S Gürsoy; O Aksel; A Ulgenalp Journal: Balkan J Med Genet Date: 2015-12-30 Impact factor: 0.519
Authors: G Bademci; F B Cengiz; J Foster Ii; D Duman; L Sennaroglu; O Diaz-Horta; T Atik; T Kirazli; L Olgun; H Alper; I Menendez; I Loclar; G Sennaroglu; S Tokgoz-Yilmaz; S Guo; Y Olgun; N Mahdieh; M Bonyadi; N Bozan; A Ayral; F Ozkinay; M Yildirim-Baylan; S H Blanton; M Tekin Journal: Sci Rep Date: 2016-08-26 Impact factor: 4.379